Pharmaceutical Technology publishes the results of an interview with DDL based on the CDMO’s experience and expertise in understanding how to overcome “Challenges in Clinical Manufacturing for Topical Drugs”; March 2, 2020, Pharmaceutical Technology Volume 44, Issue 3, pg 30-31

services-dow-development

DDL’s CMC Manager, Jason Carbol, describes current trends and how to overcome challenges in topical product manufacturing, scale up and packaging in a Pharmaceutical Technology March 2020 publication. Key topics include variability of dosing topical products in the clinic, unique scale up challenges with respect to semi-solid drug products, and the complicated nature of semi-solid product development.

http://www.pharmtech.com/challenges-clinical-manufacturing-topical-drugs